Skip to main content
. 2024 Feb 14;8:34. doi: 10.1038/s41698-024-00526-9

Fig. 1. Clinical timeline including tumor markers, research sample collections, and treatments.

Fig. 1

Solid circles represent specimen collection timepoints. Light blue line indicates CEA levels. Dark blue line indicates PSA levels. PSA prostate-specific antigen, CEA carcinoembryonic antigen, cfDNA cell-free DNA, ADT androgen deprivation therapy, PARPi Poly(ADP-ribose) polymerase inhibitor combination.